Exploring the Clinical Development of the Fatty Acid Binding Protein 5 (FABP5) inhibitor ART26.12
- FABP5 inhibitors as strategies for increasing endocannabinoid tone leading to analgesia
- Update on recent phase 1 clinical data
- Consideration of next steps